Company
Company > Company Management

Mr. Liu Yi, Vice President, President and Chief Technology Officer of Medical Technology Management Committee of Fosunpharma Group and Chief Executive Officer of CML

Mr. Liu Yi, born in August 1975, is a senior engineer. He was a student in Young Cadre Training Class of Chinese Academy of Governance from September 1998 to July 2000 ;Mr. Liu served as the deputy section officer of the Medical Equipment Department and the section officer of the Market Supervision Department of State Food and Drug Administration (Currently China Food and Drug Administration from July 2000 to August 2004, Deputy Head and Head of Beijing Medical Equipment Laboratory from November 2015 to December 2016, and Chief Technology Officer of Medical Devices Division of the Company from November 2015 to December 2016.

Mr. Liu Yi obtained a bachelor’s degree in Engineering from Beijing Institute of Technology in July 1998 and a master’s degree in Management from Peking University in January 2006.

Mr. Zhang Hao, Senior Vice President, Fosunpharma Medical Device Division and Chief Operating Officer of CML

From July, 1999 to March, 2003, he served as a Cardiac and Thoracic Surgeon at Chang Hai Hospital, The Second Military Medical University.  From March, 2003 to June, 2008, he worked on Product, Technical Sales and Marketing for Johnson and Johnson, Medtronic Medical and St. Jude Medical successively.  From June, 2008 to May, 2019, he performed multiple roles at Siemens Healthcare and his roles and responsibilities cover Product, Marketing and Channel and Direct Sales Management.

Mr. Zhang Hao had his Master of Medicine, Cardiac and Thoracic Surgery in Chang Hai Hospital, the Second Military Medical University in Shanghai, China.

Mr. Guojun Bu, Assistant General Manager of Fosunpharma Finance Department, Vice President of Medical Technology Management Committee, Vice President of Chindex Medical Limited

Mr. Guojun Bu brings more than 20 years of financial management experience in medical and healthcare industry, in particular in finance operation, financing and investment activities.

Mr. Guojun Bu graduated from Beijing University of Technology, the People’s Republic of China, majoring in Economic Information Management and obtained a master’s degree in Computer Science and Technology from Beijing University of Technology and an EMBA degree from Rutgers, the State University of New Jersey, the United States, respectively.

Ms. Ren Hai Ping, Chief Technology Officer of Medical Device Division

Ms. Ren Hai Ping holds the Doctor of Medicine degree from Chinese Academy of Medical Sciences, Chinese Union Medical College with the major in Imaging and Nuclear Medicine. Before she joins in Chindex, She had 16 years working experience in China Institute of Food and Drug Control holding the position of Director of Division of Active Medical Devices.  She holds multiple positions in Medical Device technology, management and supervision aspects including the Chairman of Artificial Intelligence Medical Device Working Group,IEEE, Member of Medical Device Technical Evaluation Expert Advisory Committee of NMPA and etc..

 

Mr. Xu Gang, Vice President of CML and Fosunpharma Medical Device Division
 
Mr. Xu holds an MBA from the Hong Kong Economic College Graduate School. He serves as Deputy General Manager of Medical Device division within Shanghai Fosun Pharmaceutical (Group) Co., Ltd. He is also Deputy General Manager of Shanghai Innovation and Technology Co., Ltd, and Shanghai Transfusion Technology Co, Ltd.

Mr. Zhang Peng, Vice President for Blood Processing Department, CML

Mr. Zhang Peng joined the company in 2002 and until 2005 served as Deputy General Manager of Shanghai Transfusion Technology Co., Ltd. (Chuangxin).
 
Since 2006 he has held the position of General Manager. 
 
Mr. Zhang Peng has a BS degree in Clinical Medicine from Chongqing Medical University and a MS degree in Medical Sciences from Katholieke Universiteit Leuven. 

 

© 2016-2017. All rights reserved by Chindex Medical Limited
互联网药品信息服务资格证编号(京)-非经营性-2018-0062